>
Medical Developments International logo

MVP - Medical Developments International Share Price

A$5.9 -0.0  -0.5%

Last Trade - 7:10am

Sector
Healthcare
Size
Small Cap
Market Cap £228.8m
Enterprise Value £212.0m
Revenue £13.5m
Position in Universe 460th / 1899
Bullish
Bearish
Unlock MVP Revenue
Momentum
Relative Strength (%)
1m +3.57%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
11.6 15.5 18.4 17.5 21.3 22.9 26.0 26.1 +14.5%
+74.5 +1.9 +14.9 -86.7 +288.8 -64.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, MedicalDevelopments International Ltd revenues increased 13% toA$12.6M. Net loss totaled A$1.1M vs. income of A$240K.Revenues reflect Pharmaceuticals segment increase of 50% toA$10M. Net loss reflects Other expenses increase fromA$820K to A$4.2M (expense), Administration expensesincrease of 44% to A$2.9M (expense). Basic Earnings perShare excluding Extraordinary Items totaled to -A$0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for MVP
Graphical History

Revenue

MVP Revenue Unlock MVP Revenue

Net Income

MVP Net Income Unlock MVP Revenue

Normalised EPS

MVP Normalised EPS Unlock MVP Revenue

PE Ratio Range

MVP PE Ratio Range Unlock MVP Revenue

Dividend Yield Range

MVP Dividend Yield Range Unlock MVP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MVP EPS Forecasts Unlock MVP Revenue
Profile Summary

Medical Developments International Limited is an Australia-based healthcare company. The Company is engaged in the manufacture and distribution of a pharmaceutical drug, and medical and veterinary equipment. The Company operates through three segments: Pharmaceuticals, Medical Devices and Veterinary products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia and the United Kingdom, and some sales in New Zealand, Eastern Europe, the Middle East and South America. The Medical Devices segment is engaged in the sale of medical devices, particularly the Space Chamber and Breath-Alert PeakFlow meters, primarily within Australia and New Zealand, and some sales in Asia, Europe, the Middle East and North America. The Veterinary Products segment is engaged in the sale of veterinary products within Australia, Europe and the United States. The Company offers a range of products in the areas of pain management, and asthma and resuscitation.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated September 16, 2003
Public Since December 15, 2003
No. of Shareholders: n/a
No. of Employees: 65
Sector Healthcare
Industry Pharmaceuticals
Index S&P/ASX All Ordinaries , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 69,454,260
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MVP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MVP
Upcoming Events for MVP
Frequently Asked Questions for Medical Developments International
What is the Medical Developments International share price?

As of 7:10am, shares in Medical Developments International are trading at A$5.9, giving the company a market capitalisation of £228.8m. This share price information is delayed by 15 minutes.

How has the Medical Developments International share price performed this year?

Shares in Medical Developments International are currently trading at A$5.9 and the price has moved by -24.46% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medical Developments International price has moved by -42.49% over the past year.

What are the analyst and broker recommendations for Medical Developments International?

Of the analysts with advisory recommendations for Medical Developments International, there are there are currently 2 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Medical Developments International is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Medical Developments International next release its financial results?

Medical Developments International is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Medical Developments International dividend yield?

Medical Developments International does not currently pay a dividend.

Does Medical Developments International pay a dividend?

Medical Developments International does not currently pay a dividend.

When does Medical Developments International next pay dividends?

Medical Developments International does not currently pay a dividend.

How do I buy Medical Developments International shares?

To buy shares in Medical Developments International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Medical Developments International?

Shares in Medical Developments International are currently trading at A$5.9, giving the company a market capitalisation of £228.8m.

Where are Medical Developments International shares listed? Where are Medical Developments International shares listed?

Here are the trading details for Medical Developments International:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: MVP
What kind of share is Medical Developments International?

Based on an overall assessment of its quality, value and momentum, Medical Developments International is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Medical Developments International share price forecast 2021?

Shares in Medical Developments International are currently priced at A$5.9. At that level they are trading at 19.22% discount to the analyst consensus target price of 0.00.

Analysts covering Medical Developments International currently have a consensus Earnings Per Share (EPS) forecast of -0.054 for the next financial year.

How can I tell whether the Medical Developments International share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medical Developments International. Over the past six months, the relative strength of its shares against the market has been -10.34%. At the current price of A$5.9, shares in Medical Developments International are trading at -1.8% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Medical Developments International PE Ratio?

We were not able to find PE ratio data for Medical Developments International.

Who are the key directors of Medical Developments International?

Medical Developments International's management team is headed by:

David Williams - NED
Robert Johnston - NED
Mark Edwards - CFO
Christine Emmanuel - NID
Brent MacGregor - CEO
Gordon Naylor - NEC
Mary Sontrop - NED
Who are the major shareholders of Medical Developments International?

Here are the top five shareholders of Medical Developments International based on the size of their shareholding:

Williams (David John) Individual Investor
Percentage owned: 13.35% (9.52m shares)
M & G Investment Management Ltd. Investment Advisor
Percentage owned: 5.09% (3.63m shares)
M&G Recovery Fund Mutual Fund
Percentage owned: 5.09% (3.63m shares)
Netwealth Investments Ltd. Investment Advisor
Percentage owned: 2.27% (1.62m shares)
Hancock (Russell Kay) Individual Investor
Percentage owned: 2.27% (1.61m shares)
Similar to MVP
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.